US 9630924
Heterocyclic compound
granted A61KA61K31/4375A61K31/472
Quick answer
US patent 9630924 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/4375, A61K31/472, A61K31/4741, A61P